Overview
Nam Kim practices practicing medicine in Seoul, Republic of Korea.
His clinical expertise encompasses Doxorubicin-Induced Cardiomyopathy, Cardiomyopathy Due to Anthracyclines, Abdominal Obesity Metabolic Syndrome, and Metabolic Syndrome.
He is actively involved in clinical research, co-authoring 27 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Nam S. Kim
Is Nam S. Kim a top-rated expert for Doxorubicin-Induced Cardiomyopathy?
MediFind is an objective health platform that identifies experts based on real-world data. Nam S. Kim is classified as an Experienced expert for Doxorubicin-Induced Cardiomyopathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Nam S. Kim participate in research or clinical trials?
Yes. Nam S. Kim has published 27 articles and abstracts on conditions like Doxorubicin-Induced Cardiomyopathy. You can view a list of Nam S. Kim's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Abdominal Obesity Metabolic Syndrome
- Cardiomyopathy Due to Anthracyclines
- Doxorubicin-Induced Cardiomyopathy
- Metabolic SyndromeMr. Kim isExperienced. Learn about Metabolic Syndrome.